Ratio of M2 Tumor-Associated Macrophages As a Better Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer.
Jianmin Xu,Qingyang Feng,Wenju Chang,Yihao Mao,Wentao Tang,Ye Wei,Li Ren,Guodong He,Yunshi Zhong,Dexiang Zhu,Jingwen Chen,Tuo Yi,Qi Lin,Meiling Ji
DOI: https://doi.org/10.1200/jco.2018.36.15_suppl.e15582
IF: 45.3
2018-01-01
Journal of Clinical Oncology
Abstract:e15582 Background: For stage II colon cancer, the effect of postoperative adjuvant chemotherapy is still controversial. M2 subtype of tumor-associated macrophages (TAMs) play an important role in promoting tumor progression. This study determined M2 TAMs as prognostic and predictive factor for adjuvant chemotherapy for stage II colon cancer. Methods: From 2009-07 to 2012-06, 521 patients with pathological stage II colon cancer were included. TAMs were detected using tissue microarray and immunohistochemistry (total TAMs by CD68; M2 subtype by CD206), also was MSI status. The density of total TAMs, M2 TAMs, and M2 TAMs / total TAMs ratio (M2 TAMs ratio) were calculated. Results: High M2 TAMs ratio was significantly associated with reduced disease-free survival (P < 0.001) and overall survival (P < 0.001), and had better prognostic power than M2 TAMs density, total TAMs density, and other clinicopathological high-risk factors. Furthermore, only patients with high M2 TAMs ratio can benefit from adjuvant chemotherapy, not only in total study population, but also in subgroup with clinicopathological high-risk factors (Table 1). Conclusions: For stage II colon cancer, M2 TAMs ratio was a good prognostic and predictive biomarker for postoperative adjuvant chemotherapy. It might facilitate patient counselling and individualise management. Table 1: M2 TAMs ratio as predictor for adjuvant chemotherapy Subgroup Total population T3 with high-risk factors or T4 M2 TAMs ratio Low High Low High Chemotherapy Yes n = 190 No n = 245 Yes n = 50 No n = 36 Yes n = 129 No n = 62 Yes n = 40 No n = 14 3-year DFS rate (%) 86.8 88.2 68.0 38.9 84.5 87.1 65.0 21.4 Log-rank P value 0.986 0.003* 0.660 0.001* HR 0.996 0.417 0.859 0.285 95% CI 0.614-1.615 0.225-0.771 0.435-1.696 0.132-0.616 Interaction P value 0.023* 0.024* 5-year OS rate (%) 90.3 91.5 75.8 47.8 88.8 89.5 74.7 37.5 Log-rank P value 0.706 0.029* 0.989 0.039* HR 1.129 0.460 0.996 0.389 95% CI 0.601-2.119 0.225-0.942 0.404-2.479 0.153-0.988 Interaction P value 0.063 0.136 HR: hazard ratio; CI: confidence interval; high-risk factors: according to NCCN guidelines for colon cancer; bold font: P < 0.1; *: P < 0.05.